A preliminary study utilizing viable HLA mismatched cultured glioma cells as adjuvant therapy for patients with malignant gliomas.

Published

Journal Article

Full Text

Duke Authors

Cited Authors

  • Bullard, DE; Thomas, DG; Darling, JL; Wikstrand, CJ; Diengdoh, JV; Barnard, RO; Bodmer, JG; Bigner, DD

Published Date

  • February 1985

Published In

Volume / Issue

  • 51 / 2

Start / End Page

  • 283 - 289

PubMed ID

  • 3966985

Pubmed Central ID

  • 3966985

International Standard Serial Number (ISSN)

  • 0007-0920

Digital Object Identifier (DOI)

  • 10.1038/bjc.1985.41

Language

  • eng

Conference Location

  • England